Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?
Saved in:
| Title: | Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed? |
|---|---|
| Authors: | Di Noia, Vincenzo1 (AUTHOR) vincenzo.dinoia@ifo.it, Pimpinelli, Fulvia2 (AUTHOR), Renna, Davide1 (AUTHOR), Campo, Flaminia3 (AUTHOR), Cosimati, Antonella4 (AUTHOR), Torchia, Andrea4 (AUTHOR), Marcozzi, Benedetta5 (AUTHOR), Massacci, Alice5 (AUTHOR), Pallocca, Matteo5 (AUTHOR), Pellini, Raul3 (AUTHOR), Morrone, Aldo6 (AUTHOR), Cognetti, Francesco7 (AUTHOR) |
| Source: | European Journal of Cancer. Nov2022, Vol. 176, p164-167. 4p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
